Levetiracetam versus carbamazepine monotherapy in newly or recently diagnosed partial epilepsy

Phase 3, randomised, open-label trial in epilepsy and Focal Onset Epilepsy comparing Keppra monotherapy with Tegretol monotherapy (2 arms). Primary endpoint: Proportion of subjects remaining seizure free during the 6-month evaluation period.